ResearcherShanghai Medical College of Fudan UniversityNo recent work listed

Ke Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-7982-5758; OpenAlex author ID A5100365688. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2023: 1 paper

Papers 1

M2 macrophage-derived exosomal miR-193b-3p promotes progression and glutamine uptake of pancreatic cancer by targeting TRIM62. Co-author DOI 10.1186/s13062-023-00356-y ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Linjia Peng · 1 shared paper, 2023 · strength 0.22
- Paper M2 macrophage-derived exosomal miR-193b-3p promotes progression and glutamine uptake of pancreatic cancer by targeting … DOI 10.1186/s13062-023-00356-y ↗
Huifeng Gao · 1 shared paper, 2023 · strength 0.22
- Paper M2 macrophage-derived exosomal miR-193b-3p promotes progression and glutamine uptake of pancreatic cancer by targeting … DOI 10.1186/s13062-023-00356-y ↗
Hao Hui Chen · 1 shared paper, 2023 · strength 0.22
- Paper M2 macrophage-derived exosomal miR-193b-3p promotes progression and glutamine uptake of pancreatic cancer by targeting … DOI 10.1186/s13062-023-00356-y ↗
Luming Liu · 1 shared paper, 2023 · strength 0.22
- Paper M2 macrophage-derived exosomal miR-193b-3p promotes progression and glutamine uptake of pancreatic cancer by targeting … DOI 10.1186/s13062-023-00356-y ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.